Barcoded Pseudoviral Libraries for Viral Entry Resistance Mapping
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for studying viral entry proteins, particularly those of less-studied viruses, are challenging due to their complex structure and difficulty in biochemical and structural analysis, hindering the development of effective therapeutic agents and vaccines.
Innovation Solution
The development of cell-stored barcoded viral protein libraries that utilize modified viral backbones with inducible promoters and reporters, along with controlled expression environments, to facilitate the generation and analysis of variant viral entry proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional methods are used to study viral entry proteins, then direct biochemical analysis can be performed, but the complex structure and difficulty of analysis hinder therapeutic development
Solution Approach 1:
The patent creates pseudoviral particles that copy the essential functional features of dangerous viruses without containing the actual viral genome. These pseudoparticles express viral entry proteins on their surface and can be engineered with barcoded genetic sequences, allowing researchers to study viral protein functions, mutations, and interactions with therapeutic agents without handling the complex and dangerous authentic viral genomes, thus simplifying analysis while maintaining measurement precision
Solution Approach 2:
The patent introduces pseudoviral particles as an intermediary system between researchers and dangerous viruses. These particles serve as safe substitutes that mediate the study of viral entry mechanisms, allowing high-throughput screening of mutations and therapeutic agents without requiring direct manipulation of complex viral genomes, thereby resolving the contradiction between analysis capability and structural complexity
2Reliability
If high-safety biocontainment facilities are used to study dangerous viruses, then safety is ensured, but research accessibility and efficiency are reduced
Solution Approach 1:
The patent replaces dangerous viral genomes with pseudoviral particles that copy only the necessary functional elements (entry proteins) while omitting the hazardous replicative genome. This allows research to be conducted in standard laboratory settings without requiring high-safety biocontainment facilities, dramatically improving accessibility while maintaining safety through the inherent non-replicating nature of the pseudoparticles
Solution Approach 2:
The patent converts the harmful aspect of viral replicability into a benefit by using non-replicating pseudoviral particles. The inability of these particles to replicate independently becomes a safety feature that eliminates biosafety concerns, allowing widespread research accessibility without compromising safety, thus resolving the contradiction between reliability and ease of operation
3Loss of information
If mutational scanning is performed on viral proteins, then resistance predictions can be made, but the process requires complex library generation and screening
Solution Approach 1:
The patent creates a universal pseudoviral platform that can simultaneously accommodate multiple barcoded viral entry protein variants in a single library. Each pseudoparticle carries a unique barcode linked to specific protein mutations, enabling high-throughput mutational scanning where thousands of variants can be screened in parallel for resistance predictions, greatly reducing the complexity of library generation and screening while maintaining accurate resistance prediction
Solution Approach 2:
The patent uses barcoded genetic copies of viral entry protein sequences integrated into the pseudoviral particles. These barcodes serve as simplified proxies that allow high-throughput sequencing and analysis to track and characterize multiple mutations simultaneously, converting the complex task of analyzing diverse viral proteins into a manageable genotypic screening process that maintains resistance prediction accuracy while reducing operational complexity
Data Source
AI summary
Cell-stored barcoded viral protein libraries with are described. The libraries can be used to map resistance mutations to therapeutic treatments. The libraries include features that allow efficient collection and assessment of informative data, obviating many bottlenecks of previous approaches.